ISSN 2149-2263 | E-ISSN 2149-2271
pdf
The Use of Clopidogrel in Patients with Coronary Artery Disease [Anatol J Cardiol]
Anatol J Cardiol. 2004; 4(1): 63-72

The Use of Clopidogrel in Patients with Coronary Artery Disease

Erdal Çavuşoğlu1
Interventional Cardiology SUNY Downstate Medical Center, Brooklyn, New York, USA

Coronary thrombosis plays a central role in the development, progression, and complications of atherosclerotic heart disease. As a result, pharmacologic manipulation of the hemostatic system has been the mainstay of treatment for coronary artery disease. Since platelets are the most important cellular element in the development of arterial thrombosis, many of the most effective therapies have involved the use of various antiplatelet agents. This article focuses on clopidogrel, an antiplatelet agent belonging to the class of drugs known as the thienopyridines, in the treatment of patients with coronary artery disease.

Keywords: Coronary artery disease, platelets, clopidogrel

Koroner Arter Hastalığında Klopidogrel’in Kullanımı

Erdal Çavuşoğlu1
Interventional Cardiology SUNY Downstate Medical Center, Brooklyn, New York, USA

Anahtar Kelimeler: Koroner arter hastalığı, plateletler, klopidogrel

Erdal Çavuşoğlu. The Use of Clopidogrel in Patients with Coronary Artery Disease. Anatol J Cardiol. 2004; 4(1): 63-72
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.